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Biventricular pacing for cardiac resynchronization therapy
(CRT) is a well-established treatment option for patients with
inter- and/or intraventricular conduction delay with QRS
width of more than 120 ms, systolic heart failure with
ejection fraction (EF) o35%, and persistent symptoms of
NYHA class II and higher despite optimal medical treatment.
While some patients experience a large beneﬁt from CRT,
others (so-called “nonresponders”) do not. Factors that favor
a beneﬁcial response to CRT include QRS width of 4150
ms and left bundle branch block morphology, resulting in a
class IA recommendation for CRT in these patients accord-
ing to current guidelines.1
We present the case of a patient who met all the above
criteria for a class IA indication to CRT but, following an
initial improvement of NYHA class, deteriorated owing to an
uncommon late complication of CRT implantation.Case report
We report the case of a 74-year-old patient with ischemic
cardiomyopathy due to extended 3-vessel disease with
repetitive coronary interventions. Left ventricular function
remained moderately impaired with EF 30%–35% despite
optimal heart failure medication. As electrocardiography
demonstrated left bundle branch block with a QRS width
of 180 ms, the decision for implantation of a biventricular
pacemaker/deﬁbrillator device was taken in 2011. However,
implantation of the coronary sinus lead via the leftKEYWORDS Arrhyhtmias; Catheter ablation and implantable cardioverter-
deﬁbrillator; Hemodynamics; Cardiomyopathy; Heart failure; Pacemaker;
Stent; Vascular disease(Heart Rhythm Case Reports 2016;2:425–427)
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).subclavian vein initially failed, leaving the patient with
right-sided atrial and ventricular leads only. Because daily
symptoms remained severe with exertional dyspnea NYHA
class III, a second attempt for coronary sinus lead implanta-
tion was conducted in 2013 and succeeded without apparent
complications. Two months later, both exercise tolerance
and left ventricular function had signiﬁcantly improved to
NYHA II and EF 44%, respectively.
In 2015, the patient reported a drastic decrease in exercise
tolerance within a week, with dyspnea after a few steps of
walking. Pacemaker control at that time revealed 99%
biventricular pacing. Echocardiography demonstrated a dif-
fuse deterioration of left ventricular function with an EF of
26%, and physical examination revealed a new left-sided
continuous bruit, as well as a thrill in the middle subclavian
region. Computed tomography demonstrated a large ﬁstula
between the left subclavian artery and the subclavian vein
with a connecting oriﬁce of 6 mm (Video 1, available online,
and Figure 1). The shunt volume was estimated by duplex
sonography to approximately 2 L/min (Figure 2). We
hypothesized that the deterioration of left ventricular func-
tion and exercise tolerance was attributable to the volume
overload associated with the shunt. Implantation of a covered
stent graft (Be-Graft 8/27 mm) via the femoral artery was
performed (Video 2, available online, and Figure 3). Both
postinterventional angiography and duplex sonography
demonstrated no residual shunting. The patient experienced
a signiﬁcant improvement of subjective functional capacity
and was able to climb a ﬂight of stairs within a few days of
the intervention.
A regular follow-up for reevaluation of left ventricular
function was scheduled at 3 months. Unfortunately, the
patient experienced non-ST-segment elevation myocardial
infarction requiring stenting of the right coronary artery
2 weeks before scheduled follow-up. Echocardiography waspen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2016.06.005
Figure 2 Doppler/duplex sonography with the pulsed-wave doppler
window within the arteriovenous ﬁstula demonstrates a calculated ﬂow
volume of 2021 cc/min.
KEY TEACHING POINTS
 Procedure-related complications can lead to
deterioration of otherwise stable heart failure in
cardiac resynchronization therapy patients and
should be actively sought for.
 High-ﬂow arteriovenous ﬁstulas can present as a late
complication several years following pacemaker
implantation.
 A thorough physical examination including
auscultation of the pacemaker-sided periclavicular
area can help to diagnose arteriovenous ﬁstulas.
Heart Rhythm Case Reports, Vol 2, No 5, September 2016426performed following coronary intervention and demon-
strated an EF of 30%.Discussion
Arteriovenous ﬁstulas (AVF) are infrequent complications in
patients requiring cardiac pacemakers and are reported
mostly following pacemaker lead extraction, rather than
implantation. In this setting, Cronin et al2 reported AVFs
in only 8 out of 2471 patients (0.3%) that underwent
pacemaker lead extraction. In only 1 of these cases, the
AVF was located at the subclavian vessels. Surprisingly,
most cases of AVF in this study were recognized not during
the procedure, but only up to 587 days later. As in our case,
the presence of a continuous bruit over the anterior chest was
a consistent ﬁnding.
The etiology of AVF development following lead extrac-
tion or, as in our case, lead implantation remains poorly
understood. Direct trauma to the artery owing to inadvertent
puncture and subsequent local arteriovenous shuntingFigure 1 Preinterventional contrast-enhanced computed tomography (left si
demonstrates the course of the arteriovenous ﬁstula.preventing closure of the puncture site might play an
important role in the development of AVF early following
the intervention. Because Cronin et al reported a delayed
diagnosis of AVF following lead explantation in most cases,
we presume that AVF size increases over time until the shunt
volume is large enough to produce a signiﬁcant bruit or
hemodynamic symptoms. Following lead implantation, local
compression to the vessel wall might contribute to late de
novo formation of AVF, but clinical data to support this
hypothesis are unavailable.
The hemodynamic consequences of AVF are mostly
studied in the context of AVF that were placed for
hemodialysis. In these patients, central upper arm AVF were
associated with almost 2-fold higher ﬂow rates compared
with peripheral forearm ﬁstulas.3 As a consequence, invasive
hemodynamic measurement revealed increased cardiac out-
put in patients with upper arm ﬁstulas.3de) and computed tomography angiography (right side). A yellow line
Figure 3 Preinterventional angiography via the femoral artery with the tip
of the catheter located in the proximal subclavian artery shows large
amounts of contrast media ﬂowing through the ﬁstula into the subclavian
vein.
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owing to increased AVF shunt volumes is well recognized,
large controlled studies on this topic are scarce. Basile et al4
found that a cutoff shunt volume of 2 L/min was predictive
for the development of high-output heart failure. Although
their calculations were based on a very limited number of
patients in a subgroup with NYHA class III symptoms, it was
considered a landmark study when published in 2008. More
recently, an independent group also reported a higher risk for
heart failure with shunt volumes of 2 L/min or more.5 As a
consequence, a shunt volume of 2 L/min or more is
recommended for diagnosis of high-output heart failure.6
Of note, these recommendations refer to patients without a
history of heart failure for other reasons.Our patient presented with a calculated shunt ﬂow of 2.1
L/min. Taking into account his underlying heart disease and
severe symptoms despite otherwise optimal medical treat-
ment, the decision was taken for an interventional approach
to close the AVF by covered stenting. His functional status
improved signiﬁcantly over the following days, demonstrat-
ing that closure of high-ﬂow AVF should be evaluated in this
patient subset.
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